Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,162 | 322 | 98.7% |
| Education | $81.58 | 11 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,839 | 86 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $683.59 | 32 | $0 (2024) |
| PFIZER INC. | $509.71 | 38 | $0 (2024) |
| Novo Nordisk Inc | $458.53 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $429.00 | 21 | $0 (2023) |
| ABBVIE INC. | $378.48 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $341.94 | 21 | $0 (2023) |
| Amgen Inc. | $310.07 | 15 | $0 (2024) |
| Lilly USA, LLC | $181.27 | 9 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $150.06 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $645.12 | 29 | AstraZeneca Pharmaceuticals LP ($196.64) |
| 2023 | $1,091 | 54 | AstraZeneca Pharmaceuticals LP ($199.57) |
| 2022 | $935.38 | 49 | Biohaven Pharmaceutical Holding Company Ltd. ($150.06) |
| 2021 | $1,056 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($224.85) |
| 2020 | $459.15 | 24 | AstraZeneca Pharmaceuticals LP ($135.26) |
| 2019 | $732.03 | 44 | AstraZeneca Pharmaceuticals LP ($347.75) |
| 2018 | $322.25 | 20 | AstraZeneca Pharmaceuticals LP ($166.32) |
| 2017 | $1,002 | 57 | AstraZeneca Pharmaceuticals LP ($439.29) |
All Payment Transactions
333 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.93 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardio-renal | ||||||
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: DIABETES | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Respiratory | ||||||
| 06/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DIABETES | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 04/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 03/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Insomnia | ||||||
| 03/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BREZTRI, AIRSUPRA | Food and Beverage | In-kind items and services | $123.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 453 | 627 | $104,712 | $46,789 |
| 2022 | 8 | 438 | 640 | $106,799 | $53,553 |
| 2021 | 12 | 878 | 1,045 | $118,105 | $54,733 |
| 2020 | 9 | 369 | 465 | $79,925 | $32,658 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 280 | $62,290 | $22,107 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 77 | 77 | $16,093 | $10,480 | 65.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 81 | 81 | $9,882 | $4,677 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 52 | $8,044 | $2,992 | 37.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 13 | $3,978 | $2,974 | 74.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 82 | 82 | $1,815 | $1,415 | 77.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,530 | $1,365 | 89.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $1,080 | $780.96 | 72.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 338 | $64,183 | $31,086 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 87 | 87 | $17,949 | $11,989 | 66.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 69 | $7,523 | $4,087 | 54.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 45 | 45 | $10,202 | $2,267 | 22.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $3,940 | $1,708 | 43.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $1,190 | $983.50 | 82.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 48 | 48 | $822.00 | $743.67 | 90.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 22 | $990.00 | $689.04 | 69.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 132 | 231 | $51,744 | $21,182 | 40.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 149 | $16,986 | $9,299 | 54.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $12,866 | $8,897 | 69.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 117 | 121 | $3,890 | $3,803 | 97.8% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 86 | 86 | $4,300 | $3,620 | 84.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 58 | 58 | $21,460 | $3,002 | 14.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 119 | 123 | $2,680 | $2,447 | 91.3% |
| 90653 | Vaccine for influenza for injection into muscle, inactivated | Office | 2021 | 21 | 21 | $1,680 | $1,250 | 74.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 34 | 34 | $1,088 | $672.18 | 61.8% |
About Dr. Betina Gideon-Greer, M.D
Dr. Betina Gideon-Greer, M.D is a General Practice healthcare provider based in Riverside, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316924582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Betina Gideon-Greer, M.D has received a total of $6,244 in payments from pharmaceutical and medical device companies, with $645.12 received in 2024. These payments were reported across 333 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,162).
As a Medicare-enrolled provider, Gideon-Greer has provided services to 2,138 Medicare beneficiaries, totaling 2,777 services with total Medicare billing of $187,734. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty General Practice
- Location Riverside, CA
- Active Since 12/28/2005
- Last Updated 03/05/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1316924582
Products in Payments
- FARXIGA (Drug) $1,286
- JARDIANCE (Drug) $482.49
- ELIQUIS (Drug) $326.53
- NURTEC ODT (Drug) $268.65
- BREZTRI (Drug) $268.17
- Ozempic (Drug) $267.67
- JANUVIA (Drug) $256.95
- STIOLTO RESPIMAT (Drug) $224.14
- UBRELVY (Drug) $211.19
- Aimovig (Biological) $151.25
- SHINGRIX (Biological) $147.40
- Otezla (Drug) $130.66
- QULIPTA (Drug) $125.33
- COLOGUARD DNA CAPTURE REAGENTS (Device) $116.03
- Rybelsus (Drug) $113.57
- ENTRESTO (Drug) $109.32
- ANORO (Drug) $107.63
- SYMBICORT (Drug) $100.41
- Kerendia (Drug) $88.48
- Cologuard Collection Kit (Device) $80.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Riverside
Dr. Samir Tadha, D.d.s, D.D.S
General Practice — Payments: $3,504
Jose Manalese, Dds, DDS
General Practice — Payments: $2,351
Dr. Negeendokht Zareh, Dmd, DMD
General Practice — Payments: $2,341
Steven Frost, Dds, DDS
General Practice — Payments: $2,083
Yudi Sugiono, Dds, DDS
General Practice — Payments: $2,020
Dr. Prabha Dhalla, M.d, M.D
General Practice — Payments: $1,988